CVR 44151197Private limited company (ApS)Fremstilling af medicinske og dentale instrumenter samt udstyr hertil (325000)RoskildeFounded 30 Jun 2023
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about Zeta Diagnostics ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
1
CVR, Aug 2026
-1 (-50%) over 12 months
Gross profit
1.4M
DKK, annual report 2025
Result
+1.1M
DKK, annual report 2025
Equity
-1.7M
DKK, annual report 2025
Kristian Klok Pedersen90% to under 100% of capital and votes, since 30 Jun 2023
CHRISTIAN NIELSENS FONDCVR 26324017, 5% to under 10% of capital and votes, since 31 Jul 2025
Operating company
Dandex estimate: 1 employee registered in 2026Kristian Klok Pedersensince 30 Jun 2023
90% to under 100% of capital and votesnotified 31 Jul 2025since 30 Jun 2023
CVR 263240175% to under 10% of capital and votessince 31 Jul 2025
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
25% to under 33.3% of capital and votes30 Jun 2023 to 23 Aug 2024
33.3% to under 50% of capital and votes30 Jun 2023 to 23 Aug 2024
Decided by Dandex with fixed rules from CVR and the filed annual reports, and for the auditor's report a calibrated decision model reading the auditor's text, not registered by the company. Each label links to its definition.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
30 Jun 2023 to 12 Nov 2026.
30 Jun 2023 to 12 Nov 2026.
Aug 2026, monthly: 1 employee, 1 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 3 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| FTE | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 5 | 5 | 6 | 5 | 4 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Monthly Aug 2023 to Aug 2026.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Gross profit | 416 | -359 | 1,400 |
| Operating profit | Not reported | Not reported | +570 |
| Result for the year | -14 | -3,303 | +1,087 |
| Equity | 26 | -3,277 | -1,690 |
| Total assets | 589 | 1,063 | 3,062 |
| Employees (average) | 2 | 4 | 2 |
| Credit metrics (Dandex calculations) | |||
| EBITDA | 50note 1 | -2,708note 1 | 1,018 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||
| Employee growth (vækst i antal ansatte) | Not reportednote 2 | Not reportednote 3 | -50% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||
| Capex (investeringer i anlægsaktiver) | Not reportednote 4 | Not reportednote 4 | 1,589note 5 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group. Not every period is a full year: 2023 covers 6 months (30 Jun to 31 Dec 2023). Changes against it compare periods of different length.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages. Gearing and interest coverage are multiples. Rows marked Pro hold a value in the Pro plan. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For Zeta Diagnostics ApS, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
From CVR, read 12 Nov 2026. Text such as the signing rule and purpose is shown as registered.
From CVR, read 12 Nov 2026. A change is counted each time the registry records a new value, so a corrected address or an audit firm under a new entity counts too.
8 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Revision:
Fratrådte:
KPMG P/S, den 24.06.2025.
Ny adresse: Rabalderstræde 7, 1. 1, 4000 Roskilde
Ny kommune: Roskilde
Vedtægter ændret: 31.07.2025
Kapitalforhøjelsen er besluttet den 31.07.2025.
kr. 2.105,00, indbetalt kontant, kurs 23.752,96.
Kapitalen udgør herefter kr. 42.105,00.
Vedtægter ændret: 23.08.2024
Bestyrelse:
Fratrådte:
Kasper Linde, (formand), den 23.08.2024, Danny Bøjstrup Pedersen, den 23.08.2024, Kristian Klok Pedersen, den 23.08.2024.
Tiltrådte:
Kristian Klok Pedersen, (formand), den 23.08.2024.
Direktion:
Fratrådte:
Kasper Linde, den 23.08.2024, Danny Bøjstrup Pedersen, den 23.08.2024.
Selskabet tegnes af den administrerende direktør eller af alle bestyrelsesmedlemmer i forening
Ny adresse: Inge Lehmanns Gade 10, 6., 8000 Aarhus C
Ny adresse: c/o Incuba, Inge Lehmanns Gade 10, 6., 8000 Aarhus C
Stiftelsesdato: 30.06.2023.
Virkningsdato: 30.06.2023.
Seneste vedtægtsdato: 30.06.2023.
Kapital:
kr. 40.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 40.000,00 til kurs 100,00, fuldt indbetalt.
Stiftere:
Kasper Linde, den 30.06.2023, Danny Bøjstrup Pedersen, den 30.06.2023, Kristian Klok Pedersen, den 30.06.2023.
Bestyrelse:
Kasper Linde, (formand), den 30.06.2023, Danny Bøjstrup Pedersen, den 30.06.2023, Kristian Klok Pedersen, den 30.06.2023.
Direktion:
Kasper Linde, den 30.06.2023, Danny Bøjstrup Pedersen, den 30.06.2023, Kristian Klok Pedersen, (adm. dir), den 30.06.2023.
Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af den administrerende direktør i forening med et bestyrelsesmedlem.
Første regnskabsår:
30.06.2023 - 31.12.2023.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er forskning og udvikling af lægemidler- og teknologi samt hermed beslægtet virksomhed.
3 registered in CVR.
P-number 1029523750Elektrovej 331, 2800 Kongens Lyngby
P-number 1029439792Inge Lehmanns Gade 10, 8000 Aarhus C
P-number 1030140423Rabalderstræde 7, 4000 Roskilde
